Difference between revisions of "PET Amyloid Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
m (Project Snapshot)
m (PET Amyloid Meetings/Call Summaries)
(87 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 +
:Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
 +
 +
:RSNA Staff Support: Julie Lisiecki
 +
* [http://tinyurl.com/QIBA-PET-Amyloid-Roster Roster]
 +
 +
 
==Project Snapshot==
 
==Project Snapshot==
  
Line 14: Line 20:
 
==PET Amyloid Meetings/Call Summaries==
 
==PET Amyloid Meetings/Call Summaries==
  
*[[QIBA PET Amyloid Biomarker Committee Call Summaries]]
+
*[[Media:2021_06-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|June 11, 2021]]
 +
*[[Media:2021_05-14_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|May 14, 2021]]
 +
*[[Media:2021_04-09_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-AMS.pdf|April 9, 2021]]
 +
*[[Media:2021_03-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 12, 2021]]
 +
*[[Media:2021_02-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 12, 2021]]
 +
 
 +
 
 +
 
 +
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
  
 
 
==PET Amyloid Profile Development==
 
==PET Amyloid Profile Development==
  
   
+
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]]
   
+
**[[Media:QIBA_PET Amyloid_Profile_02May2018-public-comments-and-responses.pdf | QIBA Public Comments and Responses - 2018-05-02]]
 +
 
 +
*[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] (''Closed on September 15, 2017'')
 +
**[[Media:QIBA_PET_Amyloid_Profile_15June2017_edited_per_public_comment_rl.pdf | QIBA PET-Amyloid DRAFT Profile with tracked changes - 2017-06-15]]
 +
 
 +
* [[Media:QIBA PET Amyloid Profilea.pdf| QIBA PET Amyloid Profile 2017-04-28]] (BC Vote to Release for Public Comment Form: https://goo.gl/forms/0RqF8V6HlXlUNi903)
 +
:*[[Media: QIBA PET Amyloid Profile Edits.xlsx|QIBA PET Amyloid Profile Edits and Open Issues]]
 +
 
 +
*[[Media:QIBA_AmyloidPET_10Feb2017_1clean_DRAFT.pdf | QIBA PET-Amyloid DRAFT Profile - CLEAN {Dr. Perlman}]] ''February 10, 2017'' (PDF)
 +
 
 +
*[[Media:QIBA_AmyloidPET_11Nov2016_1clean_DRAFT.pdf | QIBA PET-Amyloid DRAFT Profile - CLEAN {Dr. Perlman}]] ''November 11, 2016''  (PDF)
 +
 
 +
*[[Media:QIBA_AmyloidPET_07Jul.pdf | QIBA PET-Amyloid DRAFT Profile with tracked changes {Dr. Perlman}]] ''July 7, 2016''  (PDF)
 +
 
 +
*[[Media:QIBA_AmyloidPET_26Apr_5May.pdf | QIBA PET-Amyloid DRAFT Profile with tracked changes {Dr. Perlman}]] ''April 26 - May 5, 2016''
 +
 
 +
*[[Media:QIBA_Amyloid PET_(5)_09Dec_nopix with section 4.4 and other edits.doc | QIBA PET-Amyloid DRAFT Profile with tracked changes {Dr. Perlman}]] ''March 28, 2016''
 +
 
 
==Profile Supporting Material==
 
==Profile Supporting Material==
  
Line 27: Line 57:
  
 
   
 
   
==Reference Materials==
+
==Presentations and Reports==
 +
 
 +
*[[Media:08Jun2018_BCMeeting_Amyloid_updated.pdf | 06 08 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:11May2018_BCMeeting_Amyloid_updated.pdf | 05 11 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:13April2018_BCMeeting_Amyloid.pdf | 04 13 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:09March2018_BCMeeting_Amyloid.pdf | 03 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
 
 +
*[[Media:09Feb2018_BCMeeting_Amyloid.pdf | 02 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:12Jan2018_BCMeeting_Amyloid.pdf | 01 12 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
 +
*[[Media:QIBA-ADNI Amyloid Data Acquisition Gap Analysis v1.pdf | 01 12 2018 QIBA PET Amyloid Profile / ADNI Gap Analysis - presented by Ms. Matthews]]
 +
 
 +
*[[Media:12Oct2017_BCMeeting_Amyloid.pdf | 10 12 2017 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
 
 +
*[[Media:QIBAPETAmyloid_IAW_Conformance-9-9-2016.pdf | 09 09 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
 +
*[[Media:QIBAPETAmyloid_IAW_Conformance.pdf | 08 12 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
 +
*[[Media:2015-Amyloid-PET-DRO-Report-1.pdf | 2015-PET-Amyloid DRO Report – ''Drs. Pierce, Haynor, Sunderland, and Kinahan'' {Part I} - Discussed on 08 12 2016 WebEx]]
 +
*[[Media:2015-Amyloid-PET-DRO-Report-2.pdf | 2015-PET-Amyloid DRO Report – ''Drs. Pierce, Haynor, Sunderland, and Kinahan'' {Part II} - Discussed on 08 12 2016 WebEx]]
 +
*[[Media:ConformanceFormulae.docx | Conformance Formulae - Discussed on 08 12 2016 WebEx]]
 +
*[[Media:QIBAConformancedraft.docx | QIBA Conformance Draft - Discussed on 08 12 2016 WebEx]]
 +
 
 +
*[[Media:QIBAProject_PETAmyloid_Misalgnment_v2.pdf | 03 11 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
  
'''Presentations and Reports:'''
 
 
*[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]]
 
*[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]]
 +
 +
==QIBA Funded Projects==
 +
 +
====Round 4====
 +
*[[Media:Amyloid Profile Continued Support with Brain Phantom Development.pdf | Project (X) Amyloid Profile Continued Support with Brain Phantom Development (University of Iowa)]]
 +
 +
====Round 5====
 +
*[[Media:Analyses to Support Amyloid Imaging Profile Development.pdf | Project (A) Analyses to Support Amyloid Imaging Profile Development (ADM Diagnostics, LLC)]]
 +
 +
*[[Media:Amyloid Brain PET Test-Retest Meta-analysis.pdf | Project (E) Amyloid Brain PET Test-Retest Meta-analysis (Johns Hopkins University)]]
 +
 +
*[[Media:A PET-Metabolic Tumor Volume-DRO.pdf | Project (I) A PET-Metabolic Tumor Volume-Digital Reference Object (PET-MTV-DRO) (University of Washington)]]
 +
 +
*[[Media:A Procedure to Facilitate Greater Standardization of PET Spatial Resolution.pdf | Project (J) A Procedure to Facilitate Greater Standardization of PET Spatial Resolution (Johns Hopkins University)]]

Revision as of 16:26, 24 May 2021

Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
RSNA Staff Support: Julie Lisiecki


Project Snapshot

There is a draft Profile, and current outline of the Claim is:

  • SUVr will be the measurand
  • The claim will have two components
1) Cross-sectional: single subject scan
2) Longitudinal: following subject over time

Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.

Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)

PET Amyloid Meetings/Call Summaries


PET Amyloid BC Call Summaries Archive

PET Amyloid Profile Development

Profile Supporting Material

Working Documents

Presentations and Reports

QIBA Funded Projects

Round 4

Round 5